NICE Ltd vs Summit Therapeutics Inc — how do they compare? NICE Ltd trades at $99.78 (market cap $6.02B), while Summit Therapeutics Inc trades at $15.6 (market cap $12.06B). The key difference: Summit Therapeutics Inc is far larger — about 2× NICE Ltd's market cap. Which is the better fit depends on your goals.
| NICE | SMMT | |
|---|---|---|
Market Cap | $6.02B | $12.06B |
Sector | Technology | Health |
52-Week High | $153.44 | $26.98 |
52-Week Low | $83.15 | $12.55 |
Enterprise Value | $5.75B | $11.39B |
Trailing returns across standard periods
NICE Ltd. is a global leader in both enterprise software and cloud computing, specializing in customer experience and financial crime prevention solutions. The company's platform utilizes advanced analytics, AI, and automation to help organizations enhance customer interactions, ensure compliance, and combat fraud. NICE serves a diverse client base, including contact centers, financial institutions, and government agencies, by optimizing operations and improving service quality.
Read more on NICE →Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →